Trial Profile
Multicenter, Randomized Pilot Study of the Effect of Sorafenib Dosing Schedule on Tolerability and Drug Delivery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 25 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 May 2013 Planned end date changed from 1 Feb 2014 to 1 May 2014 as reported by ClinicalTrials.gov.
- 05 Nov 2012 Planned End Date changed from 1 Dec 2012 to 1 Feb 2014 as reported by ClinicalTrials.gov.